2010 - Updates & Insights Blog
-
Director's Note - July 2010The HIV+ Tumor Molecular Characterization Project (H+TMCP) is a new initiative with the goal of understanding the effect of HIV infection on the development of certain cancers. Center for Cancer Genomics scientific leader Dr. Daniela Gerhard remarks on the opportunities addressed by this program and the general need for progress on HIV research.
-
New Program Highlights: The CTD² Network and CGCICCG manages many programs aiming to enhance our understanding of the molecular mechanisms of cancer. The Cancer Target Discovery and Development (CTD2) Network is a new initiative tasked to bridge the gap between cancer genomics and precision oncology and the Cancer Genomic Characterization Initiative (CGCI) focuses on characterizing pediatric and rare adult cancers. In 2010, these programs were managed by CCG's then Office of Cancer Genomics.
-
Recovery Act Funds Accelerate Cancer Genomics ResearchThe National Cancer Institute (NCI) has invested a significant portion of its American Recovery and Reinvestment Act (ARRA) funds in existing cancer genomics research programs, including The Cancer Genome Atlas (TCGA)
-
Director's Note - March 2010
A 2010 note from Dr. Daniela Gerhard, Director of the Office of Cancer Genomics (OCG), then a part of the Center for Cancer Genomics. The letter welcomes cancer genomics researchers to learn about the goals and many projects of OCG.